Flomoxef: Difference between revisions
Created page with "{{Drugbox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 413515463 | IUPAC_name = <nowiki>(6R,7R)-7-[[2-(Difluoromethylsulfanyl)acetyl]amino]-3- 1-(2..." |
m Protected "Flomoxef": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)) |
||
| (One intermediate revision by one other user not shown) | |||
| Line 48: | Line 48: | ||
| molecular_weight = 496.46 g/mol | | molecular_weight = 496.46 g/mol | ||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}} | |||
==Overview== | |||
'''Flomoxef''' ([[International Nonproprietary Name|INN]]) is an [[oxacephem]] antibiotic. | '''Flomoxef''' ([[International Nonproprietary Name|INN]]) is an [[oxacephem]] antibiotic. | ||
| Line 54: | Line 58: | ||
==References== | ==References== | ||
{{reflist}} | {{reflist|2}} | ||
[[Category:Cephalosporin antibiotics]] | [[Category:Cephalosporin antibiotics]] | ||
[[Category:Tetrazoles]] | [[Category:Tetrazoles]] | ||
[[Category:Alcohols]] | [[Category:Alcohols]] | ||
[[Category: | [[Category:Drug]] | ||
[[Category:Carboxylic acids]] | [[Category:Carboxylic acids]] | ||
[[Category:Lactams]] | [[Category:Lactams]] | ||
| Line 67: | Line 71: | ||
[[Category:Amides]] | [[Category:Amides]] | ||
[[Category:Organofluorides]] | [[Category:Organofluorides]] | ||
Latest revision as of 20:59, 18 August 2015
 | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| UNII | |
| KEGG | |
| ChEMBL | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C15H18F2N6O7S2 |
| Molar mass | 496.46 g/mol |
  (what is this?) (verify) | |
|
WikiDoc Resources for Flomoxef |
|
Articles |
|---|
|
Most recent articles on Flomoxef |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Flomoxef at Clinical Trials.gov Clinical Trials on Flomoxef at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Flomoxef
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Directions to Hospitals Treating Flomoxef Risk calculators and risk factors for Flomoxef
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Flomoxef |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Flomoxef (INN) is an oxacephem antibiotic.
It has been classified as second-generation[1] and fourth-generation.[2]
References
- ↑ Masuda Z, Kurosaki Y, Ishino K, Yamauchi K, Sano S (April 2008). "Pharmacokinetic analysis of flomoxef in children undergoing cardiopulmonary bypass and modified ultrafiltration". Gen Thorac Cardiovasc Surg. 56 (4): 163–9. doi:10.1007/s11748-007-0208-5. PMID 18401677.
- ↑ Ito M, Ishigami T (1991). "The meaning of the development of flomoxef and clinical experience in Japan". Infection. 19 Suppl 5: S253–7. doi:10.1007/bf01645536. PMID 1783441.
- Pages with script errors
- CS1 maint: Multiple names: authors list
- Template:drugs.com link with non-standard subpage
- Articles with changed EBI identifier
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without InChI source
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- Cephalosporin antibiotics
- Tetrazoles
- Alcohols
- Drug
- Carboxylic acids
- Lactams
- Ethers
- Amides
- Organofluorides